Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Pediatr Blood Cancer. 2011 May 25;58(5):695–700. doi: 10.1002/pbc.23192

Table II.

Genotype frequencies and relapse free survival*

Gene Genotype Total N Relapse N RFS 95% CI HR* 95% CI HR* P value*
TS 28 bp insertion 2R/2R 83 15 0.80 .691–.877 1 reference --
2R/3R 196 38 0.79 .726–.845 1.68 0.863–3.255 0.13
3R/3R 103 27 0.73 .631–.806 1.87 0.942–3.721 0.074
3R/4R 20 7 0.60 .342–.789 3.69 1.436–9.481 0.007
MTHFR C677T C/C 224 41 0.81 .747–.854 1 reference --
C/T 187 46 0.74 .667–.798 1.61 1.036–2.505 0.034
T/T 72 20 0.70 .578–.798 1.36 0.763–2.411 0.3
MTRR A/A 144 26 0.80 .720–.860 1 reference --
G/A 225 62 0.72 .650–.770 1.95 1.175–3.227 0.01
G/G 128 23 0.81 .724–.867 1.23 0.672–2.241 0.51
GSTP1*B A/A 147 26 0.81 .738–.869 1 reference --
G/A 176 42 0.75 .678–.809 1.47 0.889–2.442 0.13
G/G 55 16 0.68 .529–.789 1.94 1.010–3.732 0.047
TPMT (460 and 719) Normal 465 98 0.78 .733–.812 1 reference
Heterozygote 31 9 0.69 .486–.828 1.86 .932–3.725 0.078
Variant 1 1 -- -- -- -- --
GSTT1 Present 433 100 0.76 .712–.794 1 reference --
Null 65 9 0.85 .740–.922 0.54 0.271–1.078 0.081
*

Adjusted for age, gender, ethnicity, and day 7 bone marrow response